| Emerging technologies for use in the study, diagnosis, and treatment of patients with COVID-19 M Tsikala Vafea, E Atalla, J Georgakas, F Shehadeh, EK Mylona, ... Cellular and molecular bioengineering 13, 249-257, 2020 | 162 | 2020 |
| Readmissions among patients with COVID‐19 E Atalla, M Kalligeros, G Giampaolo, EK Mylona, F Shehadeh, ... International journal of clinical practice 75 (3), e13700, 2021 | 94 | 2021 |
| Clinical presentation, course, and risk factors associated with mortality in a severe outbreak of COVID-19 in Rhode Island, USA, April–June 2020 E Atalla, R Zhang, F Shehadeh, EK Mylona, M Tsikala-Vafea, S Kalagara, ... Pathogens 10 (1), 8, 2020 | 32 | 2020 |
| Chest CT findings in asymptomatic cases with COVID-19: a systematic review and meta-analysis MT Vafea, E Atalla, M Kalligeros, EK Mylona, F Shehadeh, E Mylonakis Clinical radiology 75 (11), 876. e33-876. e39, 2020 | 30 | 2020 |
| Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study M Kalligeros, F Shehadeh, E Atalla, EK Mylona, S Aung, A Pandita, ... Journal of Global Antimicrobial Resistance 22, 842-844, 2020 | 24 | 2020 |
| Splenic sequestration crisis I Kane, A Kumar, E Atalla, S Nagalli | 19 | 2020 |
| Clinical outcomes of adult patients hospitalized with COVID-19 after vaccination M Kalligeros, F Shehadeh, EK Mylona, M Kaczynski, S Kalagara, E Atalla, ... Tropical Medicine and Infectious Disease 6 (4), 175, 2021 | 15 | 2021 |
| A pilot trial of thymalfasin (thymosin-α-1) to treat hospitalized patients with hypoxemia and lymphocytopenia due to coronavirus disease 2019 infection F Shehadeh, G Benitez, EK Mylona, QL Tran, M Tsikala-Vafea, E Atalla, ... The Journal of infectious diseases 227 (2), 226-235, 2023 | 14 | 2023 |
| Impact of influenza infection among adult and pediatric populations with hematologic malignancy and hematopoietic stem cell transplant: a systematic review and meta-analysis E Atalla, M Kalligeros, EK Mylona, M Tsikala-Vafea, F Shehadeh, ... Clinical Therapeutics 43 (5), e66-e85, 2021 | 8 | 2021 |
| Outcome of stem cell transplantation in HTLV-1-associated north American adult T-cell leukemia/lymphoma AH Bazarbachi, D Reef, H Narvel, R Patel, R Al Hamed, S Vikash, ... Clinical hematology international 5 (2), 78-91, 2023 | 6 | 2023 |
| Meta-analysis on impact of rituximab in patients with hematological malignancies with covid-19 infection CTR Vegivinti, TN Musunuru, RK Thakur, VK Kakumani, AK Mehta, ... Blood 140 (Supplement 1), 13189-13190, 2022 | 2 | 2022 |
| Investigating racial inequities of circulating tumor DNA (ctDNA) use in patients with non-small cell lung cancer: A real world analysis. A D'Aiello, H Narvel, AE Cali Daylan, E Atalla, S Vikash, S Solomon, ... Journal of Clinical Oncology 41 (16_suppl), 9133-9133, 2023 | 1 | 2023 |
| In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days E Atalla, E Mylonakis Annals of Internal Medicine 172 (12), JC67, 2020 | 1 | 2020 |
| Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study TO Jensen, TA Murray, GA Grandits, MK Jain, B Grund, K Shaw-Saliba, ... The Lancet Microbe, 2024 | | 2024 |
| Outcomes of Helicobacter pylori (HP) infection in esophageal cancer (EC): A 5-year nationwide analysis. S Vikash, F Vikash, A Mehta, F Bteich, R Al Hamed, K Neupane, ... Journal of Clinical Oncology 41 (16_suppl), e16079-e16079, 2023 | | 2023 |
| Web-based patient educational material on chimeric antigen receptor T-cell therapy: Quantitative assessment of readability. RK Thakur, A Adhikari, K Neupane, MBB Hammami, CTR Vegivinti, ... Journal of Clinical Oncology 41 (16_suppl), 11040-11040, 2023 | | 2023 |
| Factors Associated With Enrollment into Inpatient Coronavirus Disease 2019 Randomized Controlled Trials: A Cross-sectional Analysis M Kaczynski, G Benitez, EK Mylona, QL Tran, E Atalla, M Tsikala-Vafea, ... Open Forum Infectious Diseases 10 (5), ofad197, 2023 | | 2023 |
| Effect of thymalfasin (Thymosin-α-1) on reversing lymphocytopenia among patients with COVID-19 G Benitez, F Shehadeh, EK Mylona, QL Tran, M Tsikala-Vafea, E Atalla, ... International Immunopharmacology 116, 109831, 2023 | | 2023 |
| Older Age and Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Illness Severity and COVID-Related Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms … A D'Aiello, S Zareef, E Atalla, A Abbasi, K Pradhan, A Lombardo, F Khatun, ... Blood 140 (Supplement 1), 10949-10950, 2022 | | 2022 |
| In utero exposure to systemic antibiotics vs reference penicillins was not linked to congenital malformations E Atalla, E Mylonakis Annals of Internal Medicine 172 (10), JC56, 2020 | | 2020 |
